Abstract:Severe fever with thrombocytopenia syndrome (SFTS) is a rapidly progressive infectious disease triggered by a novel bunyavirus (SFTSV). Despite the critical role of host lipid metabolism in viral infections, research on dyslipidemia in SFTS remains limited. This retrospective study included 433 SFTS patients, who were stratified into survival group (n = 365) and death group (n = 68) and who were treated at the Shandong Public Health Clinical Center from September 2021 to December 2023. Additionally, 96 healthy controls with matching baseline characteristics were included from Shandong Provincial Hospital. Cross-sectional analysis based on admission data and longitudinal analysis over time were employed to survey the correlation between serum lipid profiles and mortality in SFTS patients. SFTS patients exhibited elevated triglyceride (TG) levels and reduced total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels compared to healthy individuals. Cross-sectional analysis demonstrated that lower LDL-C and apolipoprotein-B (ApoB) levels were related to elevated mortality risk in SFTS patients. Longitudinal analysis demonstrated that LDL-C and ApoB levels remained consistently lower in the death group, while TG levels gradually declined, and HDL-C levels gradually increased as the disease progressed. SFTS patients exhibit significant dyslipidemia compared to healthy individuals. Lower LDL-C and ApoB levels may independently influence mortality in SFTS patients. Elevated TG and reduced HDL-C levels may associate with disease progression. In recent years, research into Severe Fever with Thrombocytopenia Syndrome (SFTS) has intensified; however, there remains a paucity of studies addressing SFTS through the lens of serum lipid metabolism. It is well-documented that lipid metabolism plays a pivotal role in viral infections, as evidenced by numerous investigations across various viral diseases. Crucially, examining SFTS from the perspective of lipid metabolism not only enhances our understanding of viral pathogenesis but may also yield valuable insights for therapeutic interventions. This study provides a thorough examination of the serum lipid profiles in SFTS patients from a clinical perspective. Our findings first establish that SFTS patients exhibit significant lipid metabolic dysregulation compared to healthy controls. Furthermore, both cross-sectional and longitudinal analyses reveal a notable correlation between low-density lipoprotein cholesterol (LDL-C) and apolipoprotein-B (ApoB) levels and the prognosis of SFTS patients. Finally, our research opens new avenues for future investigations into SFTS by emphasizing the importance of lipid metabolism.

Clinical Characteristics and Immune Status of Patients with Severe Fever with Thrombocytopenia Syndrome.

Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome.

The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection

Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome

CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS).

Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome Patients.

Decreased Monocyte Subsets and TLR4-mediated Functions in Patients with Acute Severe Fever with Thrombocytopenia Syndrome (SFTS).

Dynamic Changes in the Immunological Characteristics of T Lymphocytes in Surviving Patients with Severe Fever with Thrombocytopenia Syndrome (SFTS).

Severe Fever with Thrombocytopenia Syndrome Bunyavirus-Related Human Encephalitis

Decreased Myeloid Dendritic Cells Indicate a Poor Prognosis in Patients with Severe Fever with Thrombocytopenia Syndrome.

Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome

Meta-analysis of the Clinical and Laboratory Parameters of SFTS Patients in China.

Study on the clinical characteristics of severe fever with thrombocytopenia syndrome caused by bunyavirus patients and analysis of routine blood and serum enzymology

Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome

Analysis of Severe Fever with Thrombocytopenia Syndrome in Critical Ill Patients in Central China.

Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection.

Clinical Progress and Risk Factors for Death from Severe Fever with Thrombocytopenia Syndrome: A Multihospital Retrospective Investigation in Anhui, China.

Dyslipidemia in severe fever with thrombocytopenia syndrome patients: A retrospective cohort study

Prolonged coagulation times in severe fever with thrombocytopenia syndrome virus infection, the indicators of heparin‐like effect and increased haemorrhagic risk

Risk Factors for Mortality in Severe Fever with Thrombocytopenia Syndrome Patients with Central Nervous System Complications